“Complement Inhibition in Rare Kidney Disease: Response Heterogeneity and Biomarker-Guided Withdrawal”. Translational Medicine & Therapeutics Journal, vol. 4, no. 1, Apr. 2025, pp. 28-36, https://doi.org/10.5281/zenodo.22649336.